Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
Etienne Ho Kit Mok(University of British Columbia), Terence K. Lee(Hong Kong Polytechnic University), Hoi-Wing Leung(Chinese University of Hong Kong), D. M. H. Baker(Smithsonian Tropical Research Institute), Martina Mang Leng Lei(Hong Kong Polytechnic University), Stephanie Ma(University of Hong Kong - Shenzhen Hospital), Jonathan D. Cybulski(University of Hong Kong), Dan Lindholm(Linköping University), Irene Oi‐Lin Ng(University of Hong Kong), Jing‐Ping Yun(Ministry of Agriculture and Rural Affairs), Eunice Y. Lau(Queen Elizabeth Hospital), Man Tong(Chinese University of Hong Kong), Jun Yu(Yueyang Second People's Hospital), Lei Zhou(Zhengzhou University), Carmen Leung(Hong Kong Polytechnic University), Hui Zhu, Jin Ding(Jinhua Central Hospital), Kin Sum Leung(Norwegian Womens Public Health Association), Chi Ho Lin(Education University of Hong Kong), Tin Lok Wong(University of Hong Kong)
Cited by 106
Related Papers
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
|Cell stem cell|2018|723
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
|Nature Reviews Gastroenterology & Hepatology|2021|472
Understanding the gut microbiota and sarcopenia: a systematic review
|Journal of Cachexia Sarcopenia and Muscle|2021|340